| Dr Jeffery Lovell Mellor, OD, MED | |
|
10412 S 2200 W, South Jordan, UT 84095-8333 | |
| (801) 858-2020 | |
| (801) 610-2138 |
| Full Name | Dr Jeffery Lovell Mellor |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 19 Years |
| Location | 10412 S 2200 W, South Jordan, Utah |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518975226 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 328094-9934 (Utah) | Primary |
| Provider Name | Wasatch View Eye Care L L C |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1285927129 PECOS PAC ID: 5991937294 Enrollment ID: O20140422000023 |
News Archive
Increased focus on providing optimum patient care in the most cost efficient way is fuelling demand for intelligent infusion devices termed "Smart Pumps." A report from InMedica, a division of IMS Research (recently acquired by IHS Inc. (NYSE:IHS)), on the global market for infusion pumps found that, despite market saturation in the developed countries, demand for advanced technology is being maintained; infusion pump suppliers must offer technically advanced products at competitive prices to maintain market share.
AGA Medical Holdings, Inc. today announced the Düsseldorf Regional Court has awarded €2.1 million in damages to AGA Medical as a result of a patent infringement case filed by AGA Medical against Occlutech GmbH (Occlutech), based in Jena, Germany. AGA Medical is a leading developer of interventional devices for the minimally invasive treatment of structural heart defects and vascular abnormalities.
Levels of carbonic anhydrase 9 increase with the use of vascular endothelial growth factor-targeted therapy for metastatic clear-cell renal cancer, and high expression of this protein is associated with increased survival, show study results reported in European Urology.
Forbes Medi-Tech Inc. ("Forbes" or "Company") announced today that it has received a Nasdaq Staff Deficiency Letter indicating that it does not meet The Nasdaq Capital Market initial listing standard set forth in Listing Rule 5505 and unless the Company requests an appeal of the Staff's determination, the Company's common shares will be suspended at the opening of business on January 15, 2010, and a Form 25-NSE will be filed with the Securities and Exchange Commission which will remove the Company's common shares from listing and registration on The Nasdaq Stock Market.
› Verified 4 days ago
| Provider Name | Eye Care For Kids |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1336294750 PECOS PAC ID: 1355691163 Enrollment ID: O20180828004241 |
News Archive
Increased focus on providing optimum patient care in the most cost efficient way is fuelling demand for intelligent infusion devices termed "Smart Pumps." A report from InMedica, a division of IMS Research (recently acquired by IHS Inc. (NYSE:IHS)), on the global market for infusion pumps found that, despite market saturation in the developed countries, demand for advanced technology is being maintained; infusion pump suppliers must offer technically advanced products at competitive prices to maintain market share.
AGA Medical Holdings, Inc. today announced the Düsseldorf Regional Court has awarded €2.1 million in damages to AGA Medical as a result of a patent infringement case filed by AGA Medical against Occlutech GmbH (Occlutech), based in Jena, Germany. AGA Medical is a leading developer of interventional devices for the minimally invasive treatment of structural heart defects and vascular abnormalities.
Levels of carbonic anhydrase 9 increase with the use of vascular endothelial growth factor-targeted therapy for metastatic clear-cell renal cancer, and high expression of this protein is associated with increased survival, show study results reported in European Urology.
Forbes Medi-Tech Inc. ("Forbes" or "Company") announced today that it has received a Nasdaq Staff Deficiency Letter indicating that it does not meet The Nasdaq Capital Market initial listing standard set forth in Listing Rule 5505 and unless the Company requests an appeal of the Staff's determination, the Company's common shares will be suspended at the opening of business on January 15, 2010, and a Form 25-NSE will be filed with the Securities and Exchange Commission which will remove the Company's common shares from listing and registration on The Nasdaq Stock Market.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffery Lovell Mellor, OD, MED 15037 Winged Bluff Ln, Draper, UT 84020-5719 Ph: (801) 649-3692 | Dr Jeffery Lovell Mellor, OD, MED 10412 S 2200 W, South Jordan, UT 84095-8333 Ph: (801) 858-2020 |
News Archive
Increased focus on providing optimum patient care in the most cost efficient way is fuelling demand for intelligent infusion devices termed "Smart Pumps." A report from InMedica, a division of IMS Research (recently acquired by IHS Inc. (NYSE:IHS)), on the global market for infusion pumps found that, despite market saturation in the developed countries, demand for advanced technology is being maintained; infusion pump suppliers must offer technically advanced products at competitive prices to maintain market share.
AGA Medical Holdings, Inc. today announced the Düsseldorf Regional Court has awarded €2.1 million in damages to AGA Medical as a result of a patent infringement case filed by AGA Medical against Occlutech GmbH (Occlutech), based in Jena, Germany. AGA Medical is a leading developer of interventional devices for the minimally invasive treatment of structural heart defects and vascular abnormalities.
Levels of carbonic anhydrase 9 increase with the use of vascular endothelial growth factor-targeted therapy for metastatic clear-cell renal cancer, and high expression of this protein is associated with increased survival, show study results reported in European Urology.
Forbes Medi-Tech Inc. ("Forbes" or "Company") announced today that it has received a Nasdaq Staff Deficiency Letter indicating that it does not meet The Nasdaq Capital Market initial listing standard set forth in Listing Rule 5505 and unless the Company requests an appeal of the Staff's determination, the Company's common shares will be suspended at the opening of business on January 15, 2010, and a Form 25-NSE will be filed with the Securities and Exchange Commission which will remove the Company's common shares from listing and registration on The Nasdaq Stock Market.
› Verified 4 days ago
Dr. Ryan J Mortensen, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 11506 S District Dr, Ste 400, South Jordan, UT 84095 Phone: 801-495-4833 Fax: 801-495-4836 | |
Utah Vision Development Center, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 3672 W South Jordan Pkwy, Ste 103, South Jordan, UT 84009 Phone: 801-810-1060 | |
Standard Optical Co Optometrist Medicare: Not Enrolled in Medicare Practice Location: 11514 S 4000 W, Bldg H Suite 103, South Jordan, UT 84009 Phone: 801-727-8711 Fax: 801-727-8714 | |
Dr. Carlyle Derek Swain, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 11328 S Jordan Gtwy, South Jordan, UT 84095 Phone: 801-571-1364 | |
Copper View Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 5474 W Daybreak Pkwy Ste G3, South Jordan, UT 84009 Phone: 801-923-3935 | |
Wasatch View Eye Care L L C Optometrist Medicare: Medicare Enrolled Practice Location: 10412 S 2200 W, South Jordan, UT 84095 Phone: 801-858-2020 Fax: 801-610-2138 | |
Dr. Michael Sperry Hope, OD Optometrist Medicare: Medicare Enrolled Practice Location: 10654 S River Heights Dr Ste 110, South Jordan, UT 84095 Phone: 801-676-2020 |